Significant medical improvements occur specific to lipids, systolic and diastolic blood pressure, and blood glucose levels. Liver transaminases are reduced as is high sensitivity C-reactive protein, so the patient may experience less inflammation.  Obese patients with type 2 diabetes often are able to reduce their need for insulin or medication, and can potentially reverse their condition. 

Additional positive improvements are experienced by patients with cardiovascular issues, osteoarthritis, nephrological conditions, cancer, non-alcoholic fatty liver disease and other serious health conditions. 

Using a VLCD as part of a weight loss program helps patients lose weight and keep it off more effectively than other weight loss approaches. 

While medical benefits are important, many people with obesity have struggled with weight and failed attempts at weight loss over the course of their lives. Using a VLCD leads not only to weight loss, but also a reduction in waist circumference, fat mass and android fat. Being able to see and feel a difference in their bodies and health can have a tremendous impact on their quality of life. 

For patients, the cost for a VLCD program is notably lower than bariatric surgery, which sometimes is (erroneously) viewed as the only weight loss options for people with severe obesity. In addition, the cost of a VLCD program is similar in cost to traditional grocery foods as calculated by the USDA. VLCDs are convenient, portable, easy to use, and offer a range of food. This results in a greater level of enthusiasm and motivation because patients find the program to be tolerable and appealing, leading to greater success and more significant results.

As health care continues to push value-based care initiatives, the efficacy and proven outcomes of a medically-supervised VLCD program supports this initiative to help reduce costs throughout the entire health care continuum. 

For hospitals and medical providers challenged by the pressures of increased health care costs, declining reimbursements and reduced patient census, starting a medically-supervised VLCD program supported by Robard can aid in establishing a net-new revenue stream that supports patient alignment and engagement.  

Using Robard’s business growth, development and training resources, complimented by our scientifically designed products, a medically-supervised VLCD program helps support an integrated network of patient referrals and revenue across many service lines which helps improve outcomes, margins, patient census and patient satisfaction.